DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a Second Year of Life Booster in HIV-Exposed Infected and Uninfected Infants

Clinical trial NCT02817451 · COMPLETED

Trial details

NCT number: NCT02817451
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diphtheria Tetanus Pertussis Hepatitis B Polio Human Immunodeficiency Virus Infection

Start date: 2016-07-14
Primary completion: 2019-02-22
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.